Organization
Concert Pharmaceuticals, Inc.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Concert Pharmaceuticals, Inc.
... Concert Pharmaceuticals is reassessing whether to expand CTP-543 into additional indications after its ...
... Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that the U.S. Food and Drug Administration ...
... Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that the Patent Trial and Appeal Board (PTAB) ...
... Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced the appointment of Marc Becker as Chief Financial ...
... Therapeutics Inc., Cascadian Therapeutics, Inc., Cellectis SA, Calyxt, Inc., Chimerix, Inc., Concert Pharmaceuticals Inc., Corium International, Inc., Corbus Pharmaceuticals Holdings, Inc., CRISPR Therapeutics AG, Corvus ...
... Concert Pharmaceuticals, Inc . (NASDAQ: CNCE) today announced that it has been selected for addition ...
... S.A. Nasdaq CLXT Calyxt, Inc. Nasdaq CMRX Chimerix, Inc. Nasdaq CNCE Concert Pharmaceuticals, Inc. Nasdaq CORI Corium International Nasdaq CRBP Corbus Pharma Hlds Nasdaq CRSP ...
... Resources, Inc. (NYSE:CLR), Western Union Company (NYSE:WU), M.D.C. Holdings, Inc. (NYSE:MDC), Concert Pharmaceuticals, Inc. (NASDAQ:CNCE), and WellCare Health Plans, Inc. (NYSE:WCG), including updated fundamental summaries, ...
... LEXINGTON, Mass. - Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today reported financial results for the third quarter of 2017. ...
... Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today reported financial results for the third quarter of 2017. ...
... LEXINGTON, Mass. - Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that it will report its third quarter 2017 ...
... Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that it has completed enrollment of the ...
... Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that it will report its third quarter 2017 ...
... to its Board of Directors. Dr. Tung is the scientific co-founder of Concert Pharmaceuticals, where he serves as President and Chief Executive Officer. Prior to ...
... of VX-561 (previously known as CTP-656), an investigational once-daily CFTR potentiator, from Concert Pharmaceuticals. Non-GAAP R&D expenses were $243.2 million compared to $211.0 million for ...
... LEXINGTON, Mass. - Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that the Patent Trials and Appeal Board (PTAB) ...
... Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that the Patent Trials and Appeal Board (PTAB) ...
... Concert Pharmaceuticals, Inc . (NASDAQ: CNCE) today announced that it will present a corporate overview ...
... LEXINGTON, Mass - Concert Pharmaceuticals Inc. (NASDAQ: CNCE) today reported financial results for the second quarter of ...
... Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today reported financial results for the second quarter of 2017. ...
... Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that it will report its second quarter 2017 ...
Want to see the full history on Concert Pharmaceuticals, Inc.? Upgrade to RelSci Pro now!
Start My Free Trial